pta20210125025
Holding announcement according to article 135 section 2 BörseG
Holding announcement according to article 135 section 2 BörseG
Marinomed Biotech AG: Release according to art. 135 section 2 BörseG
Korneuburg (pta025/25.01.2021/14:15 UTC+1)
| First name | Name/Surname | City | Country |
| Mohammed | Al Sheikh | ||
| Abdulmohsen | Al Sheikh | ||
| Acropora Beteiligungs GmbH | Wien | Österreich |
| % of voting rights attached to shares (7.A) | % of voting rights through financial/other instruments (7.B.1 + 7.B.2) | Total of both in % (7.A + 7.B) | Total number of voting rights of issuer | |
| Resulting situation on the date on which threshold was crossed / reached | 13,86 % | 0,00 % | 13,86 % | 1 474 731 |
| Position of previous notification (if applicable) | 16,59 % | 0,00 % | 16,59 % |
| A: Voting rights attached to shares | ||||
| ISIN Code | Number of voting rights | % of voting rights | ||
| Direct | ||||
| (Sec 130 BörseG 2018) | Indirect | |||
| (Sec 133 BörseG 2018) | Direct | |||
| (Sec 130 BörseG 2018) | Indirect | |||
| (Sec 133 BörseG | ||||
| 2018) | ||||
| ATMARINOMED06 | 204 410 | 13,86 % | ||
| SUBTOTAL A | 204 410 | 13,86 % |
| B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018 | ||||
| Type of instrument | ||||
| Expiration Date | ||||
| Exercise Period | Number of voting | |||
| rights that may be | ||||
| acquired if the | ||||
| instrument is exercised | ||||
| % of voting rights | ||||
| SUBTOTAL B.1 |
| B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018 | |||||
| Type of instrument | Expiration Date | Exercise Period | Physical / | ||
| Cash Settlement | Number of | ||||
| voting rights | % of voting rights | ||||
| SUBTOTAL B.2 |
| No. | Name | Directly controlled by No. | Shares held directly (%) | Financial/other instruments held directly (%) | Total of both (%) |
| 1 | Abdulmohsen Al Sheikh | ||||
| 2 | Mohammed Al Sheikh | ||||
| 3 | Acropora Beteiligungs GmbH | 1,2 | 13,86 % | 13,86 % | |
(end)
| Emitter: |
Marinomed Biotech AG Hovengasse 25 2100 Korneuburg Austria |
|
|---|---|---|
| Contact Person: | Elisabeth Schön | |
| Phone: | +43226290300 | |
| E-Mail: | elisabeth.schoen@marinomed.com | |
| Website: | www.marinomed.com | |
| ISIN(s): | ATMARINOMED6 (Share) | |
| Stock Exchange(s): | Vienna Stock Exchange (Official Trade) |